share_log

ELITE PHARMACEUTICALS INC | 8-K: Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 ended September 30, 2024 and Provides Conference Call Information

ELITE PHARMACEUTICALS INC | 8-K: Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 ended September 30, 2024 and Provides Conference Call Information

ELITE PHARMACEUTICALS INC | 8-K:Elite Pharmicals, Inc. 公布截至2024年9月30日的2025财年第二季度财务业绩,并提供电话会议信息
美股SEC公告 ·  11/14 15:56
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息